Oncobox

Personalized genetic profiling to find the right cancer drug.

Pre-seed / SeedWalnut, CAFounded 2015

About

Oncobox develops molecular diagnostics that analyze tumor DNA, RNA, and molecular pathways to identify which drugs are most likely to be effective for individual cancer patients. In a study of 900 patients with various late-stage cancers, Oncobox increased the effectiveness of targeted therapies from 25% to 64%. The company's scientific advisory board includes researchers from UCLA, Stanford, and Johns Hopkins.

Total Funding

$2M

Key Product

Oncobox Dx personalized cancer drug selection

Geography

North America